| Total population | STI related complaints | Symptoms after probing | Asymptomatic |
|---|
| (n=1185) (%) | (n=360) (%) | (n=552) (%) | (n=273) (%) |
|---|
| Clinical examination | | | | |
| Normal | 380 (32.1) | 89 (24.7) | 148 (26.8) | 143 (52.4) |
| GUD | 4 (0.3) | 2 (0.6) | 2 (0.4) | 0 (0) |
| Condylomata | 14 (1.2) | 9 (2.5) | 4 (0.7) | 1 (0.4) |
| Vaginitis | 593 (50.1) | 195 (54.2) | 299 (54.2) | 99 (36.4) |
| Cervicitis | 389 (32.8) | 129 (35.8) | 200 (36.2) | 60 (22.0) |
| PID | 76 (6.4) | 38 (10.6) | 38 (6.9) | 0 (0) |
| Laboratory | | | | |
| STI | | | | |
| T vaginalis | 119/1175 (10.1) | 41/357 (11.5) | 55/547 (10.2) | 23/271 (8.5) |
| C trachomatis | 40/969 (4.1) | 16/292 (5.5) | 21/461 (4.6) | 3/216 (1.4) |
| N gonorrhoeae | 5/1162 (0.4) | 3/354 (0.8) | 2/544 (0.4) | 0/264 (0) |
| GUD | 4/1180 (0.3) | 2/359 (0.6) | 2/554 (0.4) | 0/267 (0) |
| Condylomata | 14/1184 (1.2) | 9/360 (2.5) | 4/552 (0.7) | 1/272 (0.4) |
| HIV antibodies | 0/1158 (0) | 0/356 (0) | 0/540 (0) | 0/262 (0) |
| HbsAg | 4/1180 (0.3) | 1/359 (0.3) | 1/549 (0.2) | 2/272 (0.7) |
| HBc antibodies | 43/1177 (3.7) | 15/358 (4.2) | 14/549 (2.6) | 14/270 (5.2) |
| RPR ≥1/4 | 8/1185 (0.7) | 5/360 (1.4) | 3/552 (0.5) | 0/273 (0) |
| At least one STI | 213/1175 (18.5) | 78/357 (21.8) | 95/548 (17.3) | 40/270 (14.8) |
| Non-STI RTI | | | | |
| Candida species | 224/1175 (19.1) | 74/357 (20.7) | 107/547 (19.6) | 43/271 (15.9) |
| Bacterial vaginosis | 359/1176 (30.5) | 132/358 (36.9) | 155/547 (28.3) | 72/271 (26.6) |